Subscribe

Rede D'Or São Luiz S.A. (RDOR3.SA)

BRL36.30 +0.25 (+0.69%)
BR SAO Healthcare Medical - Care Facilities
Address Rua Francisco Marengo, no 1312 03313-000
São Paulo, SP, BR
CEO Paulo Junqueira Moll
Website rededorsaoluiz.com.br
IPO 2020-12-15
ISIN BRRDORACNOR8

Explore sections of this company profile

Description

Rede D'Or São Luiz S.A. manages an extensive healthcare network across Brazil. The company delivers a comprehensive range of medical services, covering areas such as neurology, oncology, and pathology, alongside specialized treatments for hemangioma, lymphangioma, lymphatic malformation, and various vascular anomalies and tumors. Its offerings also include advanced vascular surgery, radiology, and interventional radiology. For younger patients, it provides expert care in pediatric cardiology, oncology, hematology, and surgery. This extensive enterprise comprises 51 wholly-owned hospitals, one managed hospital, and 47 oncology clinics, housing a total of 9,000 beds. Complementary services like blood banks, dialysis centers, and diverse specialized outpatient clinics are also part of its portfolio. Notably, Rede D'Or is equipped with robot surgery facilities across Brazil. Its geographical footprint extends to the states of Rio de Janeiro, São Paulo, Pernambuco, Bahia, Maranhão, Sergipe, Ceará, Paraná, and the Federal District. Founded in 1977, with its headquarters in São Paulo, Brazil, the company was previously known as Hospital Maternidade São Luiz S.A.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
BRL36.30 +0.25 (+0.69%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
9M
Beta
0.61
Float Shares
1.09B
Free Float %
49.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-6.11% -10.08% -13.12% -15.17% -23.45% -11.12% +8.47% +47.66% -46.31% -37.67% -37.67%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
36.30
DCF (Unlevered) 229.93 +533.4%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 4 0
Buy 9 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
1.89
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✓ MOAT relativo
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +10.2% ★ Q1'26: +10.6% (vs Q1'25)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +22.5% ★ Q1'26: -6.4% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +18.4% ★ Q1'26: -1.7% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +18.0% ★ Q1'26: +18.3% (vs Q1'25)
  • ✓
    ROIC Medical - Care Facilities: +6.8%
    +24.1% ★ Q1'26: +22.3% (vs Q1'25)
  • ✓
    Share dilution Medical - Care Facilities: +0.0%
    -0.6% ★ Q1'26: -0.4% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    3.72× ★ Q1'26: 3.56× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.69) × ERP
WACC = 62% × Ke + 39% × Kd (10.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 229.93 Current price: 36.30
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
5 Rev. Ana.
3 EPS Ana. 		Dec 2027
10 Rev. Ana.
7 EPS Ana. 		Dec 2028
8 Rev. Ana.
4 EPS Ana. 		Dec 2029
7 Rev. Ana.
2 EPS Ana.
Revenue
14.03B
est: 13.53B (+3.7%)
20.38B
est: 20.50B (-0.6%)
22.99B
est: 23.04B (-0.2%)
46.51B
est: 48.35B (-3.8%)
50.57B
est: 51.40B (-1.6%)
55.73B
est: 56.48B (-1.3%)
62.48B
61.84B – 63.29B
+10.6% YoY
69.23B
67.86B – 70.92B
+10.8% YoY
77.62B
76.99B – 78.25B
+12.1% YoY
84.37B
83.49B – 85.45B
+8.7% YoY
EBITDA
2.67B
est: 3.06B (-12.7%)
5.14B
est: 4.64B (+10.7%)
6.08B
est: 5.22B (+16.5%)
8.05B
est: 11.57B (-30.4%)
12.74B
est: 12.30B (+3.6%)
14.22B
est: 13.52B (+5.2%)
14.95B
14.80B – 15.15B
+10.6% YoY
16.57B
16.24B – 16.97B
+10.8% YoY
18.58B
18.43B – 18.73B
+12.1% YoY
20.19B
19.98B – 20.45B
+8.7% YoY
EBIT
1.82B
est: 2.28B (-20.1%)
3.91B
est: 3.46B (+13.0%)
4.67B
est: 3.89B (+20.2%)
6.55B
est: 8.63B (-24.1%)
8.96B
est: 9.18B (-2.4%)
10.03B
est: 10.09B (-0.5%)
11.16B
11.04B – 11.30B
+10.6% YoY
12.36B
12.12B – 12.67B
+10.8% YoY
13.86B
13.75B – 13.97B
+12.1% YoY
15.07B
14.91B – 15.26B
+8.7% YoY
Net Income
428.33M
est: 677.05M (-36.7%)
1.58B
est: 1.91B (-17.7%)
1.19B
est: 1.47B (-18.6%)
2.04B
est: 3.17B (-35.6%)
3.85B
est: 3.70B (+3.9%)
4.69B
est: 4.69B (+0.0%)
5.07B
5.00B – 5.15B
+8.2% YoY
6.46B
6.07B – 6.95B
+27.3% YoY
7.82B
6.90B – 8.59B
+21.1% YoY
—
— – —
-100.0% YoY
SGA
213.07M
est: 177.84M (+19.8%)
295.10M
est: 269.40M (+9.5%)
298.71M
est: 302.78M (-1.3%)
612.21M
est: 792.69M (-22.8%)
500.09M
est: 842.74M (-40.7%)
1.75B
est: 926.02M (+89.3%)
1.02B
1.01B – 1.04B
+10.6% YoY
1.14B
1.11B – 1.16B
+10.8% YoY
1.27B
1.26B – 1.28B
+12.1% YoY
1.38B
1.37B – 1.40B
+8.7% YoY
EPS
0.22
est: 0.30 (-27.9%)
0.80
est: 0.86 (-7.3%)
0.53
est: 0.66 (-19.8%)
0.91
est: 1.43 (-36.6%)
1.73
est: 1.68 (+3.3%)
2.12
est: 2.09 (+1.2%)
2.30
2.26 – 2.33
+9.6% YoY
2.87
2.75 – 3.15
+25.1% YoY
3.49
3.13 – 3.89
+21.4% YoY
—
— – —
-100.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-08 B 3/5 1/5 5/5 4/5 1/5 3/5 2/5
2026-05-07 B 3/5 1/5 5/5 4/5 1/5 3/5 2/5
2026-05-06 B 3/5 1/5 5/5 4/5 1/5 3/5 2/5
2026-05-05 B 3/5 1/5 5/5 4/5 1/5 3/5 2/5
2026-05-04 B 3/5 1/5 5/5 4/5 1/5 3/5 2/5
2026-04-30 B 3/5 1/5 5/5 4/5 1/5 3/5 2/5
2026-04-29 B 3/5 1/5 5/5 4/5 1/5 3/5 2/5
2026-04-28 B 3/5 1/5 5/5 4/5 1/5 3/5 2/5
2026-04-27 B 3/5 1/5 5/5 4/5 1/5 3/5 2/5
2026-04-24 B 3/5 1/5 5/5 5/5 1/5 3/5 2/5
2026-04-23 B 3/5 1/5 5/5 5/5 1/5 3/5 2/5
2026-04-22 B 3/5 1/5 5/5 5/5 1/5 3/5 2/5
2026-04-20 B 3/5 1/5 5/5 5/5 1/5 3/5 2/5
2026-04-17 B 3/5 1/5 5/5 5/5 1/5 3/5 2/5
2026-04-16 B 3/5 1/5 5/5 5/5 1/5 3/5 2/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-1.99B
OE per share TTM
-0.90
Owner's Yield
-2.36%
Maintenance CapEx ratio
8.01%
Maint CapEx / Avg PPE
44.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 159 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 OTG Latin America ETF OTGL 2.02% 436.5K 0.95%
2 Global X - MSCI SuperDividend Emerging Markets ETF SDEM 1.99% 878.3K 0.66%
3 iShares MSCI Brazil ETF EWZ 1.21% 111.12M 0.59%
4 Franklin FTSE Brazil UCITS ETF FLXB.L 1.14% 1.81M 0.19%
5 Franklin FTSE Brazil ETF FLBR 1.13% 6.15M 0.19%
6 iShares Latin America 40 ETF ILF 1.11% 41.58M 0.47%
7 Invesco FTSE Emerging Markets High Dividend Low Volatility UCITS ETF EMHD.L 1.00% 2.85M 0.49%
8 iShares MSCI Brazil UCITS ETF USD (Dist) IDBZ.L 0.98% 4.98M 0.74%
9 iShares MSCI Brazil UCITS ETF (DE) 4BRZ.DE 0.98% 46.29M 0.27%
10 Xtrackers MSCI Brazil UCITS ETF 1C XMBD.L 0.98% 2.55M 0.25%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
141.3K
Shares Outstanding
2.20B

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Jamil Muanis Neto Director & Member of Executive Board — male
Leandro Reis Tavares Director & Member of Executive Board — male
Mauro Teixeira Sampaio Director & Member of Executive Board — male
Otavio de Garcia Lazcano Member of Executive Board, Chief Financial Officer & Investor Relations Officer — male
Paulo Junqueira Moll Chief Executive Officer & Member of Executive Board — male
Roberta de Carolis Périssé Duarte Company Secretary — —
Rodrigo Gavina da Cruz Director & Member of Executive Board — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities